Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
202,731,676
-
Total 13F shares
-
33,780,657
-
Share change
-
-4,705,547
-
Total reported value
-
$293,597,463
-
Put/Call ratio
-
8.9%
-
Price per share
-
$8.69
-
Number of holders
-
120
-
Value change
-
-$49,310,574
-
Number of buys
-
65
-
Number of sells
-
55
Institutional Holders of Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) as of Q3 2021
As of 30 Sep 2021,
Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) was held by
120 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
33,780,657 shares.
The largest 10 holders included
EVENTIDE ASSET MANAGEMENT, LLC, STATE STREET CORP, VANGUARD GROUP INC, BlackRock Inc., Alpine Global Management, LLC, TWO SIGMA INVESTMENTS, LP, EcoR1 Capital, LLC, TWO SIGMA ADVISERS, LP, MORGAN STANLEY, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
116
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.